NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT00237627 2012-05-18Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerUNC Lineberger Comprehensive Cancer CenterPhase 1/2 Completed107 enrolled
NCT00378781 2012-02-24Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionM.D. Anderson Cancer CenterPhase NA Withdrawn